Multi-Cancer Early Detection Blood Test
Early-stage and pre-disease cancer detection
Pre-clinical/ValidationActive
Key Facts
Indication
Early-stage and pre-disease cancer detection
Phase
Pre-clinical/Validation
Status
Active
Company
About Harbinger Health
Harbinger Health, incubated by Flagship Pioneering and launched in 2021, is developing a novel paradigm for cancer screening focused on detecting the disease before tumors form or symptoms appear. The company's platform integrates AI with proprietary biology to identify early cancer-associated biological programs, with the goal of creating a low-cost, multi-cancer blood test. Led by CEO Ajit Singh, Ph.D., the company is in the pre-clinical/development stage and presented early performance data at ASCO 2025. Harbinger seeks to shift cancer care from reactive treatment to proactive pre-emption, targeting a massive unmet need in oncology diagnostics.
View full company profile